#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Janet Adolphson Email
Research Associate . Cocrystal Pharma
Tucker, GA
Locationj*********@cocrystalpharma.com
Primary EmailHow to contact Janet Adolphson
Join and see Janet's contact info for free!Current Roles
Employees:
22Revenue:
$3.4MAbout
Cocrystal Pharma, Inc. (NASDAQ: COCP) is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. CC-31244 is a Phase 2a ready broad-spectrum novel non-nucleoside replication inhibitor of HCV. Phase 1b studies in HCV infected patients showed the largest reduction in viral load of any non-nucleoside inhibitor tested to date. The next step for CC-31244 is clinical trials as part of a cocktail for ultra-short therapy of 2 to 4 weeks. The lead candidate for influenza has advanced to IND-enabling studies. It is effective in animal models against both the pandemic and seasonal strains of influenza. In addition, the Company has a pipeline of promising early preclinical programs. Two private investors own approximately 54% of the Company. Corporate investors include OPKO Health, Inc., Brace Pharma Capital, LLC and Teva Pharmaceuticals Industries, Ltd.Cocrystal Pharma Address
19805 North Creek ParkwayTucker, GA
United States